Articles
Pharma gets social – LillyPad provides platform for Lilly's corporate engagement

Pharma gets social – LillyPad provides platform for Lilly's ...

In his latest article, Daniel Ghinn explores the processes behind the launch of LillyPad and speaks with Greg Kueterman, from Lilly, on his experiences in getting the regulatory team on board and looking after the social media channels. It is almost two years since Lilly took its first deliberate steps into corporate engagement via social media with the launch of its...

Articles
FDA guidelines and social media for the pharma industry

FDA guidelines and social media for the pharma industry

Rodica Ceslov explores the challenge of meeting regulatory compliance with regards to social media use within the pharmaceutical. The challenge associated with social media and the pharmaceutical industry is how to meet regulatory compliance while utilizing this...

Articles
HR in emerging markets – cultural learnings for the benefit of a business...

HR in emerging markets – cultural learnings for the benefit ...

Alan Dixon provides a light-hearted take on the comparisons between business strategies in the west, with those in emerging markets. Not quite the politically correct start to an article on “emerging” or should we say “fast developing” markets...but one that recognises that...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more